Literature DB >> 18027862

Quality of life and everyday activities in patients with primary biliary cirrhosis.

Carlo Selmi1, M Eric Gershwin, Keith D Lindor, Howard J Worman, Ellen B Gold, Mitchell Watnik, Jessica Utts, Pietro Invernizzi, Marshall M Kaplan, John M Vierling, Christopher L Bowlus, Marina G Silveira, Ilaria Bossi.   

Abstract

UNLABELLED: Primary biliary cirrhosis (PBC) is generally a slowly progressive disease that may lead to cirrhosis and liver failure. However, patients with PBC often suffer from a variety of symptoms long before the development of cirrhosis that include issues of daily living that have an impact on their work environment and their individual quality of life. We therefore examined multiple parameters by taking advantage of the database of our cohort of 1032 patients with PBC and 1041 matched controls. The data were obtained from patients from 23 tertiary referral centers throughout the United States and from rigorously matched controls by age, sex, ethnicity, and random-digit dialing. The data showed that patients with PBC were more likely than controls to have significant articular symptoms, a reduced ability to perform household chores, and the need for help with routine activities. Patients with PBC rated their overall activity similar or superior to that of controls; however, more of them reported limitations in their ability to carry out activities at work or at home and difficulties in everyday activities. PBC cases also more frequently reported limitations in participating in certain sports or exercises and pursuing various hobbies; however, they did not report significant limitations in social activities. In a multivariable analysis, household income, a diagnosis of systemic lupus erythematosus, limitations in work activities, a reduction in work secondary to disability, and church attendance were independently increased in PBC cases with respect to controls.
CONCLUSION: Our data indicate that the quality of life of patients with PBC in the United States is generally well preserved. Nevertheless, patients with PBC suffer significantly more than controls from a variety of symptoms that are beyond the immediate impact of liver failure and affect their lifestyle, personal relationships, and work activities.

Entities:  

Mesh:

Year:  2007        PMID: 18027862      PMCID: PMC3148769          DOI: 10.1002/hep.21953

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  28 in total

1.  Psychosocial factors associated with perceived disease severity in patients with chronic hepatitis C: relationship with information sources and attentional coping styles.

Authors:  Aymery Constant; Laurent Castera; Bruno Quintard; Pierre-Henri Bernard; Victor de Ledinghen; Patrice Couzigou; Marilou Bruchon-Schweitzer
Journal:  Psychosomatics       Date:  2005 Jan-Feb       Impact factor: 2.386

2.  Epidemiology of autoimmune diseases in Denmark.

Authors:  William W Eaton; Noel R Rose; Amanda Kalaydjian; Marianne G Pedersen; Preben Bo Mortensen
Journal:  J Autoimmun       Date:  2007-06-19       Impact factor: 7.094

Review 3.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

4.  Evaluation of fatigue in U.S. patients with primary biliary cirrhosis.

Authors:  Carmen M Stanca; Nancy Bach; Cynthia Krause; Nidhi Tandon; Maria A Freni; Julio A Gutierrez; Carol Bodian; Jose Lopez; Paul D Berk; Henry C Bodenheimer; Andrea D Branch; Joseph A Odin
Journal:  Am J Gastroenterol       Date:  2005-05       Impact factor: 10.864

5.  Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms.

Authors:  Larissa V Rodríguez; Daniel S Blander; Frederick Dorey; Shlomo Raz; Philippe Zimmern
Journal:  Urology       Date:  2003-07       Impact factor: 2.649

6.  Correlates of physical activity among U.S. young adults, 18 to 30 years of age, from NHANES III.

Authors:  Marsha Dowda; Barbara E Ainsworth; Cheryl L Addy; Ruth Saunders; William Riner
Journal:  Ann Behav Med       Date:  2003-08

7.  Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis.

Authors:  Carlo Selmi; Susan R Ross; Aftab A Ansari; Pietro Invernizzi; Mauro Podda; Ross L Coppel; M Eric Gershwin
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

8.  Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment.

Authors:  Carlo Selmi; Marlyn J Mayo; Nancy Bach; Hiromi Ishibashi; Pietro Invernizzi; Robert G Gish; Stuart C Gordon; Harlan I Wright; Bruce Zweiban; Mauro Podda; M Eric Gershwin
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

9.  Quality of life in patients with primary biliary cirrhosis.

Authors:  Renée Eugénie Poupon; Yves Chrétien; Olivier Chazouillères; Raoul Poupon; Judith Chwalow
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

Review 10.  Primary biliary cirrhosis: does X mark the spot?

Authors:  Carlo Selmi; Pietro Invernizzi; Monica Miozzo; Mauro Podda; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2004-11       Impact factor: 9.754

View more
  8 in total

1.  Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Authors:  Jennifer Y Lee; Christopher J Danford; Hirsh D Trivedi; Elliot B Tapper; Vilas R Patwardhan; Alan Bonder
Journal:  Dig Dis Sci       Date:  2019-01-10       Impact factor: 3.199

Review 2.  The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Kazuhito Kawata; Yoshimasa Kobayashi; M Eric Gershwin; Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

Review 3.  Clinical features and management of primary biliary cirrhosis.

Authors:  Andrea Crosignani; Pier-Maria Battezzati; Pietro Invernizzi; Carlo Selmi; Elena Prina; Mauro Podda
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 4.  The unfinished business of primary biliary cirrhosis.

Authors:  Carlo Selmi; Massimo Zuin; M Eric Gershwin
Journal:  J Hepatol       Date:  2008-07-02       Impact factor: 25.083

5.  Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort.

Authors:  Piero Luigi Almasio; Anna Licata; Marcello Maida; Fabio Salvatore Macaluso; Andrea Costantino; Nicola Alessi; Stefania Grimaudo; Giulia Accardi; Calogero Caruso; Antonio Craxi
Journal:  Hepat Mon       Date:  2016-10-16       Impact factor: 0.660

6.  Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis.

Authors:  Minami Yagi; Atsushi Tanaka; Masanori Abe; Tadashi Namisaki; Hitoshi Yoshiji; Atsushi Takahashi; Hiromasa Ohira; Atsumasa Komori; Satoshi Yamagiwa; Kentaro Kikuchi; Tetsuya Yasunaka; Akinobu Takaki; Yoshiyuki Ueno; Akira Honda; Yasushi Matsuzaki; Hajime Takikawa
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

7.  Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison.

Authors:  Lorenzo Montali; Andrea Gragnano; Massimo Miglioretti; Alessandra Frigerio; Luca Vecchio; Alessio Gerussi; Laura Cristoferi; Vincenzo Ronca; Daphne D'Amato; Sarah Elizabeth O'Donnell; Clara Mancuso; Martina Lucà; Minami Yagi; Anna Reig; Laura Jopson; Sesé Pilar; Dave Jones; Albert Pares; George Mells; Atsushi Tanaka; Marco Carbone; Pietro Invernizzi
Journal:  J Transl Autoimmun       Date:  2021-01-06

8.  Factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study.

Authors:  Katarzyna Kotarska; Ewa Wunsch; Agnieszka Kempińska-Podhorodecka; Joanna Raszeja-Wyszomirska; Dimitrios P Bogdanos; Maciej Wójcicki; Piotr Milkiewicz
Journal:  J Immunol Res       Date:  2014-03-04       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.